What does CUSIP 62957M104 represent in this 13F holders report?

CUSIP 62957M104 is the security identifier for NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR in Q2 2017?

4 institutional investors reported NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR for Q2 2017. Use the holders table for investor-level position and value details.

NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV)

CUSIP: 62957M104

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / SPONSORED ADR
Total 13F shares: 5,791,852
Share change: -9,394,109
Total reported value: $52,824,000
Price per share: $10.48
Number of holders: 4
Value change: -$120,362,723
Number of buys: 1
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 62957M104?
CUSIP 62957M104 identifies NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 62957M104:

Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016

Institutional Holders of NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV) as of Q2 2017

As of 30 Jun 2017, NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,791,852 shares. The largest 4 holders included Vivo Capital, LLC, Almanack Investment Partners, LLC., Hillhouse Capital Management, Ltd., and Boxer Capital, LLC. This page lists 4 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.